Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128


CTLA4 blockade broadens the peripheral T-cell receptor repertoire.

Robert L, Tsoi J, Wang X, Emerson R, Homet B, Chodon T, Mok S, Huang RR, Cochran AJ, Comin-Anduix B, Koya RC, Graeber TG, Robins H, Ribas A.

Clin Cancer Res. 2014 May 1;20(9):2424-32. doi: 10.1158/1078-0432.CCR-13-2648. Epub 2014 Feb 28. Erratum in: Clin Cancer Res. 2015 Jul 15;21(14):3359.


Modulation of cell signaling networks after CTLA4 blockade in patients with metastatic melanoma.

Comin-Anduix B, Sazegar H, Chodon T, Matsunaga D, Jalil J, von Euw E, Escuin-Ordinas H, Balderas R, Chmielowski B, Gomez-Navarro J, Koya RC, Ribas A.

PLoS One. 2010 Sep 15;5(9):e12711. doi: 10.1371/journal.pone.0012711.


TRAV gene expression in PBMCs and TILs in patients with breast cancer analyzed by a DNA melting curve (FQ-PCR) technique for TCR α chain CDR3 spectratyping.

He XY, Yang WM, Tang WT, Ma R, Sun YP, Wang P, Yao XS.

Neoplasma. 2012;59(6):693-9. doi: 10.4149/neo_2012_088.


CTLA4 blockade induces frequent tumor infiltration by activated lymphocytes regardless of clinical responses in humans.

Huang RR, Jalil J, Economou JS, Chmielowski B, Koya RC, Mok S, Sazegar H, Seja E, Villanueva A, Gomez-Navarro J, Glaspy JA, Cochran AJ, Ribas A.

Clin Cancer Res. 2011 Jun 15;17(12):4101-9. doi: 10.1158/1078-0432.CCR-11-0407. Epub 2011 May 10.


[T cell repertoires correlate with pathogenesis of chronic idiopathic thrombocytopenic purpura].

Zhu X, Zhu P, Guo XL.

Zhonghua Yi Xue Za Zhi. 2005 Dec 14;85(47):3316-22. Chinese.


DNA demethylating agent decitabine broadens the peripheral T cell receptor repertoire.

Nie J, Zhang Y, Li X, Chen M, Liu C, Han W.

Oncotarget. 2016 Jun 21;7(25):37882-37892. doi: 10.18632/oncotarget.9352.


Limited T cell receptor repertoire diversity in tuberculosis patients correlates with clinical severity.

Luo W, Su J, Zhang XB, Yang Z, Zhou MQ, Jiang ZM, Hao PP, Liu SD, Wen Q, Jin Q, Ma L.

PLoS One. 2012;7(10):e48117. doi: 10.1371/journal.pone.0048117. Epub 2012 Oct 26.


Characterization of the T-cell receptor beta chain repertoire in tumor-infiltrating lymphocytes.

Nakanishi K, Kukita Y, Segawa H, Inoue N, Ohue M, Kato K.

Cancer Med. 2016 Sep;5(9):2513-21. doi: 10.1002/cam4.828. Epub 2016 Jul 27.


Profiling the T-cell receptor repertoire of patient with pleural tuberculosis by high-throughput sequencing.

Li D, Gao G, Li Z, Sun W, Li X, Chen N, Sun J, Yang Y.

Immunol Lett. 2014 Nov;162(1 Pt A):170-80. doi: 10.1016/j.imlet.2014.08.012. Epub 2014 Aug 27.


T lymphocytes infiltrating the liver during chronic hepatitis C infection express a broad range of T-cell receptor beta chain diversity.

Vigan I, Jouvin-Marche E, Leroy V, Pernollet M, Tongiani-Dashan S, Borel E, Delachanal E, Colomb M, Zarski JP, Marche PN.

J Hepatol. 2003 May;38(5):651-9.


Detailed analysis of immunologic effects of the cytotoxic T lymphocyte-associated antigen 4-blocking monoclonal antibody tremelimumab in peripheral blood of patients with melanoma.

Comin-Anduix B, Lee Y, Jalil J, Algazi A, de la Rocha P, Camacho LH, Bozon VA, Bulanhagui CA, Seja E, Villanueva A, Straatsma BR, Gualberto A, Economou JS, Glaspy JA, Gomez-Navarro J, Ribas A.

J Transl Med. 2008 May 1;6:22. doi: 10.1186/1479-5876-6-22.


Analysis of the CDR3 region of alpha/beta T-cell receptors (TCRs) and TCR BD gene double-stranded recombination signal sequence breaks end in peripheral blood mononuclear cells of T-lineage acute lymphoblastic leukemia.

Xin-Sheng Y, Zheng-Jun X, Li M, Wan-Bang S, Wei-Yang Z, Qian W, Zhi-Ming H, Min-Jie M, Ying L, Zhen-Qiang W, Xiao-Wei H, Ju-Fang W, Xiao-Ning W.

Clin Lab Haematol. 2006 Dec;28(6):405-15.


Modulation of lymphocyte regulation for cancer therapy: a phase II trial of tremelimumab in advanced gastric and esophageal adenocarcinoma.

Ralph C, Elkord E, Burt DJ, O'Dwyer JF, Austin EB, Stern PL, Hawkins RE, Thistlethwaite FC.

Clin Cancer Res. 2010 Mar 1;16(5):1662-72. doi: 10.1158/1078-0432.CCR-09-2870. Epub 2010 Feb 23.


Composition and variation analysis of the TCR β-chain CDR3 repertoire in systemic lupus erythematosus using high-throughput sequencing.

Sui W, Hou X, Zou G, Che W, Yang M, Zheng C, Liu F, Chen P, Wei X, Lai L, Dai Y.

Mol Immunol. 2015 Oct;67(2 Pt B):455-64. doi: 10.1016/j.molimm.2015.07.012. Epub 2015 Jul 27.


Analysis of the Repertoire Features of TCR Beta Chain CDR3 in Human by High-Throughput Sequencing.

Hou X, Wang M, Lu C, Xie Q, Cui G, Chen J, Du Y, Dai Y, Diao H.

Cell Physiol Biochem. 2016;39(2):651-67. doi: 10.1159/000445656. Epub 2016 Jul 21.


Molecular analysis of TCR clonotypes in LGL: a clonal model for polyclonal responses.

O'Keefe CL, Plasilova M, Wlodarski M, Risitano AM, Rodriguez AR, Howe E, Young NS, Hsi E, Maciejewski JP.

J Immunol. 2004 Feb 1;172(3):1960-9.


CTLA4 blockade increases Th17 cells in patients with metastatic melanoma.

von Euw E, Chodon T, Attar N, Jalil J, Koya RC, Comin-Anduix B, Ribas A.

J Transl Med. 2009 May 20;7:35. doi: 10.1186/1479-5876-7-35.


Supplemental Content

Support Center